Bill
A 1303
Bill A 1303 establishes strict safety standards for menstrual products, funds health research, and promotes consumer education to enhance product safety and reduce health risks.
Bill Number: A 1303
Title: Relates to the Menstrual Product Safety and Research Act
Status: Referred to Health
Introduced: January 09, 2025
Classification: Bill
The primary purpose of Bill A 1303 is to enhance the safety and efficacy of menstrual products through comprehensive research and regulation. The bill aims to ensure that menstrual products available in the market are safe for consumer use, addressing potential health risks associated with these products.
Safety Standards: The bill proposes the establishment of stringent safety standards for menstrual products, including tampons, pads, and menstrual cups. This includes guidelines for materials used, manufacturing processes, and labeling requirements.
Research Initiatives: A significant component of the bill is the allocation of funds for research into the health impacts of menstrual products. This research will focus on identifying any harmful substances and their effects on users.
Consumer Education: The bill emphasizes the importance of consumer education regarding menstrual product safety. It mandates the creation of informational resources to help consumers make informed choices.
Regulatory Oversight: The bill calls for the creation of a regulatory body or the designation of an existing agency to oversee compliance with the new safety standards and to monitor the market for any unsafe products.
Manufacturers: Companies producing menstrual products will need to comply with the new safety standards and regulations, which may require changes in production processes and materials.
Consumers: Individuals who use menstrual products will benefit from increased safety and transparency regarding the products they use, potentially reducing health risks.
Healthcare Providers: Medical professionals may gain access to new research findings that can inform their guidance to patients regarding menstrual health and product safety.
Current Status: As of January 09, 2025, the bill has been referred to the Health Committee for further consideration.
Related Legislation: Bill A 1303 is part of a broader legislative effort, with related bills from prior sessions (A 572, A 689, A 463, A 512) indicating ongoing legislative interest in menstrual product safety and regulation.
Bill A 1303 represents a proactive approach to ensuring the safety of menstrual products through research, regulation, and consumer education. If enacted, it could lead to significant improvements in product safety standards and consumer awareness, ultimately benefiting public health.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
